{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T10:53:21Z","timestamp":1780484001193,"version":"3.54.1"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.phrs.2016.11.029","type":"journal-article","created":{"date-parts":[[2016,11,23]],"date-time":"2016-11-23T21:15:53Z","timestamp":1479935753000},"page":"46-53","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Paradoxical sleep deprivation in rats causes a selective reduction in the expression of type-2 metabotropic glutamate receptors in the hippocampus"],"prefix":"10.1016","volume":"117","author":[{"given":"Isabella","family":"Panaccione","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Iacovelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"di Nuzzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Nardecchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Mauro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delfina","family":"Janiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"De Blasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Sani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferdinando","family":"Nicoletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosamaria","family":"Orlando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2016.11.029_bib0005","doi-asserted-by":"publisher","first-page":"14960","DOI":"10.1073\/pnas.1516016112","article-title":"Stress dynamically regulates behavior and glutamatergic gene expression in hippocampus by opening a window of epigenetic plasticity","volume":"1","author":"Nasca","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2016.11.029_bib0010","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/mp.2014.96","article-title":"Mind the gap: glucocorticoids modulate hippocampal glutamate tone underlying individual differences in stress susceptibility","volume":"20","author":"Nasca","year":"2015","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.phrs.2016.11.029_bib0015","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1523\/JNEUROSCI.4230-10.2011","article-title":"Maternal influenza viral infection causes schizophrenia-like alterations of 5-HT\u2082A and mGlu2 receptors in the adult offspring","volume":"2","author":"Moreno","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2016.11.029_bib0020","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1038\/npp.2011.274","article-title":"Pharmacological activation of group-II metabotropic glutamate receptors corrects a schizophrenia-like phenotype induced by prenatal stress in mice","volume":"37","author":"Matrisciano","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.phrs.2016.11.029_bib0025","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1523\/JNEUROSCI.2331-12.2013","article-title":"Prenatal stress induces schizophrenia-like alterations of serotonin 2A and metabotropic glutamate 2 receptors in the adult offspring: role of maternal immune system","volume":"16","author":"Holloway","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2016.11.029_bib0030","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/B978-0-12-800977-2.00004-8","article-title":"Modeling the molecular epigenetic profile of psychosis in prenatally stressed mice","volume":"128","author":"Guidotti","year":"2014","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.phrs.2016.11.029_bib0035","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.neuroscience.2013.12.063","article-title":"5-HT(2A) and mGlu2 receptor binding levels are related to differences in impulsive behavior in the Roman Low- (RLA) and High- (RHA) avoidance rat strains","volume":"263","author":"Klein","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.phrs.2016.11.029_bib0040","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.bbr.2014.03.008","article-title":"mGluR3 knockout mice show a working memory defect and an enhanced response to MK-801 in the T- and Y-maze cognitive tests","volume":"266","author":"Lainiola","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.phrs.2016.11.029_bib0045","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1097\/01.ypg.0000056682.82896.b0","article-title":"Positive associations of polymorphisms in the metabotropic glutamate receptor type 3 gene (GRM3) with schizophrenia","volume":"13","author":"Fujii","year":"2003","journal-title":"Psychiatr. Genet."},{"key":"10.1016\/j.phrs.2016.11.029_bib0050","doi-asserted-by":"publisher","first-page":"12604","DOI":"10.1073\/pnas.0405077101","article-title":"Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia","volume":"101","author":"Egan","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2016.11.029_bib0055","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.schres.2004.07.002","article-title":"A case-control study of the relationship between the metabotropic glutamate receptor 3 gene and schizophrenia in the Chinese population","volume":"73","author":"Chen","year":"2005","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.phrs.2016.11.029_bib0060","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.schres.2005.04.001","article-title":"Association between the polymorphic GRM3 gene and negative symptom improvement during olanzapine treatment","volume":"77","author":"Bishop","year":"2005","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.phrs.2016.11.029_bib0065","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1097\/YPG.0b013e3281ac231e","article-title":"Association analysis of the metabotropic glutamate receptor type 3 gene (GRM3) with schizophrenia","volume":"17","author":"Bishop","year":"2007","journal-title":"Psychiatr. Genet."},{"key":"10.1016\/j.phrs.2016.11.029_bib0070","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/hup.1163","article-title":"Association between type-three metabotropic glutamate receptor gene (GRM3) variants and symptom presentation in treatment refractory schizophrenia","volume":"26","author":"Bishop","year":"2011","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.phrs.2016.11.029_bib0075","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s00213-014-3649-4","article-title":"Pharmacogenetic associations of the type-3 metabotropic glutamate receptor (GRM3) gene with working memory and clinical symptom response to antipsychotics in first-episode schizophrenia","volume":"232","author":"Bishop","year":"2015","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.phrs.2016.11.029_bib0080","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.1038\/sj.npp.1301669","article-title":"Expression of a GRM3 splice variant is increased in the dorsolateral prefrontal cortex of individuals carrying a schizophrenia risk SNP","volume":"33","author":"Sartorius","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.phrs.2016.11.029_bib0085","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/tpj.2009.24","article-title":"Candidate-gene association analysis of response to risperidone in African-American and white patients with schizophrenia","volume":"9","author":"Fijal","year":"2009","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.phrs.2016.11.029_bib0090","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1097\/YPG.0000000000000050","article-title":"The functional GRM3 Kozak sequence variant rs148754219 affects the risk of schizophrenia and alcohol dependence as well as bipolar disorder","volume":"24","author":"O'Brien","year":"2014","journal-title":"Psychiatr. Genet."},{"key":"10.1016\/j.phrs.2016.11.029_bib0095","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.biopsych.2006.12.005","article-title":"Altered dimerization of metabotropic glutamate receptor 3 in schizophrenia","volume":"62","author":"Corti","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.phrs.2016.11.029_bib0100","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1086\/497703","article-title":"Bipolar I disorder and schizophrenia: a 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios","volume":"77","author":"Fallin","year":"2005","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.phrs.2016.11.029_bib0105","first-page":"297","article-title":"Psychosis and relapse in bipolar disorder are related to GRM3 DAOA, and GRIN2B genotype","volume":"13","author":"Dalvie","year":"2010","journal-title":"Afr. J. Psychiatry (Johannesbg)"},{"key":"10.1016\/j.phrs.2016.11.029_bib0110","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1001\/jamapsychiatry.2013.38","article-title":"Genetic association, mutation screening, and functional analysis of a Kozak sequence variant in the metabotropic glutamate receptor 3 gene in bipolar disorder","volume":"70","author":"Kandaswamy","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.phrs.2016.11.029_bib0115","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0165-0327(02)00266-5","article-title":"A systematic review of manic and depressive prodromes","volume":"74","author":"Jackson","year":"2003","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.phrs.2016.11.029_bib0120","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.cpr.2007.07.010","article-title":"The ascent into mania: a review of psychological processes associated with the development of manic symptoms","volume":"28","author":"Mansell","year":"2008","journal-title":"Clin. Psychol. Rev."},{"key":"10.1016\/j.phrs.2016.11.029_bib0125","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S0165-1781(99)00036-0","article-title":"Rate of switch from depression into mania after therapeutic sleep deprivation in bipolar depression","volume":"86","author":"Colombo","year":"1999","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.phrs.2016.11.029_bib0130","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1176\/appi.ajp.2013.12050708","article-title":"Behavioral treatment of insomnia in bipolar disorder","volume":"170","author":"Kaplan","year":"2013","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.phrs.2016.11.029_bib0135","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/0924-977X(95)00023-I","article-title":"Sleep deprivation in the rat: an animal model of mania","volume":"5","author":"Gessa","year":"1995","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.phrs.2016.11.029_bib0140","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.bbr.2007.09.012","article-title":"Behavioural sensitization to repeated sleep deprivation in a mice model of mania","volume":"187","author":"Benedetti","year":"2008","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.phrs.2016.11.029_bib0145","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/S0091-3057(02)00843-2","article-title":"The selective group mGlu2\/3 receptor agonist LY379268 suppresses REM sleep and fast EEG in the rat","volume":"73","author":"Feinberg","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.phrs.2016.11.029_bib0150","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1124\/jpet.104.076547","volume":"312","author":"Feinberg","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.phrs.2016.11.029_bib0155","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ejphar.2008.11.018","article-title":"Modulation of group II metabotropic glutamate receptor (mGlu2) elicits common changes in rat and mice sleep-wake architecture","volume":"603","author":"Ahnaou","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.11.029_bib0160","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.bbr.2014.05.003","article-title":"Blockade of the metabotropic glutamate (mGluR2) modulates arousal through vigilance states transitions: evidence from sleep-wake EEG in rodents","volume":"270","author":"Ahnaou","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.phrs.2016.11.029_bib0165","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.bbr.2015.01.009","article-title":"Relevance of the metabotropic glutamate receptor (mGluR5) in the regulation of NREM-REM sleep cycle and homeostasis: evidence from mGluR5 (-\/-) mice","volume":"282","author":"Ahnaou","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.phrs.2016.11.029_bib0170","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.brainres.2012.03.003","article-title":"Effects of microinjections of Group II metabotropic glutamate agents into the amygdala on sleep","volume":"1452","author":"Dong","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.phrs.2016.11.029_bib0175","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.pnpbp.2012.09.011","article-title":"Effects of MPEP, a selective metabotropic glutamate mGlu5 ligand, on sleep and wakefulness in the rat","volume":"40","author":"Cavas","year":"2013","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry."},{"key":"10.1016\/j.phrs.2016.11.029_bib0180","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.pbb.2012.12.008","article-title":"Positive allosteric modulation of mGlu7 receptors by AMN082 affects sleep and wakefulness in the rat. 3","volume":"103","author":"Cavas","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.phrs.2016.11.029_bib0185","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.biopsych.2012.07.030","article-title":"Increased metabotropic glutamate receptor subtype 5 availability in human brain after one night without sleep","volume":"73","author":"Hefti","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.phrs.2016.11.029_bib0190","doi-asserted-by":"publisher","first-page":"e24933","DOI":"10.1371\/journal.pone.0024933","article-title":"Sleep-deprivation induces changes in GABA(B) and mGlu receptor expression and has consequences for synaptic long-term depression","volume":"6","author":"Tadavarty","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2016.11.029_bib0195","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.pnpbp.2009.09.019","article-title":"Adolescent development, hypothalamic-pituitary-adrenal function, and programming of adult learning and memory","volume":"34","author":"McCormick","year":"2010","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.phrs.2016.11.029_bib0200","doi-asserted-by":"publisher","first-page":"e1000412","DOI":"10.1371\/journal.pbio.1000412","article-title":"Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research","volume":"8","author":"Kilkenny","year":"2010","journal-title":"PLoS Biol."},{"key":"10.1016\/j.phrs.2016.11.029_bib0205","first-page":"281","article-title":"Effect of sodium valproate on the open-field behavior of rats","volume":"25","author":"Barros","year":"1992","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.phrs.2016.11.029_bib0210","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.physbeh.2009.11.002","article-title":"Circadian phase and sex effects on depressive\/anxiety-like behaviors and HPA axis responses to acute stress","volume":"99","author":"Verma","year":"2010","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.phrs.2016.11.029_bib0215","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.pbb.2007.02.010","article-title":"Effects of interleukin-1beta and lipopolysaccharide on behavior of mice in the elevated plus-maze and open field tests","volume":"86","author":"Swiergiel","year":"2007","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"2","key":"10.1016\/j.phrs.2016.11.029_bib0220","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyu031","article-title":"Protein kinase C inhibition rescues manic-like behaviors and hippocampal cell proliferation deficits in the sleep deprivation model of mania","volume":"18","author":"Abrial","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.phrs.2016.11.029_bib0225","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.neuropharm.2014.07.009","article-title":"Levels of the Rab GDP dissociation inhibitor (GDI) are altered in the prenatal restrain stress mouse model of schizophrenia and are differentially regulated by the mGlu2\/3 receptor agonists, LY379268 and LY354740","volume":"86","author":"Orlando","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2016.11.029_bib0230","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1111\/j.1460-9568.2005.04060.x","article-title":"Cholinergic and noncholinergic brainstem neurons expressing Fos after paradoxical (REM) sleep deprivation and recovery","volume":"9","author":"Verret","year":"2005","journal-title":"Eur. J. Neurosci."},{"issue":"1","key":"10.1016\/j.phrs.2016.11.029_bib0235","doi-asserted-by":"publisher","first-page":"e4272","DOI":"10.1371\/journal.pone.0004272","article-title":"Localization of the brainstem GABAergic neurons controlling paradoxical (REM) sleep","volume":"4","author":"Sapin","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2016.11.029_bib0240","doi-asserted-by":"publisher","first-page":"4595","DOI":"10.1021\/jm040088h","article-title":"Phenyl-tetrazolyl acetophenones: discovery of positive allosteric potentiatiors for the metabotropic glutamate 2 receptor","volume":"47","author":"Pinkerton","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.phrs.2016.11.029_bib0245","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1124\/jpet.106.102046","article-title":"Biphenyl-indanone A, a positive allosteric modulator of the metabotropic glutamate receptor subtype 2, has antipsychotic- and anxiolytic-like effects in mice","volume":"318","author":"Galici","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.phrs.2016.11.029_bib0250","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1046\/j.1365-2869.1998.00122.x","article-title":"Increased ACTH and corticosterone secretion induced by different methods of paradoxical sleep deprivation","volume":"7","author":"Suchecki","year":"1998","journal-title":"J. Sleep Res."},{"key":"10.1016\/j.phrs.2016.11.029_bib0255","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1046\/j.1365-2826.2002.00812.x","article-title":"Hormonal and behavioural responses of paradoxical sleep-deprived rats to the elevated plus maze","volume":"14","author":"Suchecki","year":"2002","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.phrs.2016.11.029_bib0260","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.pbb.2004.09.001","article-title":"The effect of venlafaxine on behaviour, body weight and striatal monoamine levels on sleep-deprived female rats","volume":"79","author":"de Oliveira","year":"2004","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.phrs.2016.11.029_bib0265","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.pnpbp.2004.11.007","article-title":"Acute cocaine effects in paradoxical sleep deprived male rats: prog","volume":"29","author":"Andersen","year":"2005","journal-title":"Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.phrs.2016.11.029_bib0270","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1080\/10284150701725938","article-title":"Pretreatment with a mixture of essential fatty acids protects rats from anxiogenic effects of REM deprivation","volume":"10","author":"Yehuda","year":"2007","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.phrs.2016.11.029_bib0275","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.pnpbp.2007.07.017","article-title":"Distinct behavioral and neurochemical alterations induced by intermittent hypoxia or paradoxical sleep deprivation in rats","volume":"32","author":"Perry","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.phrs.2016.11.029_bib0280","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.euroneuro.2009.03.005","article-title":"Modulation of sickness behavior by sleep: the role of neurochemical and neuroinflammatory pathways in mice","volume":"19","author":"Zager","year":"2009","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.phrs.2016.11.029_bib0285","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.bbr.2010.07.031","article-title":"Reciprocal interactions between MK-801, sleep deprivation and recovery in modulating rat behaviour","volume":"216","author":"Dubiela","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.phrs.2016.11.029_bib0290","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.neubiorev.2016.06.028","article-title":"Effects of experimental sleep deprivation on anxiety-like behavior in animal research: systematic review and meta-analysis","volume":"68","author":"Pires","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.phrs.2016.11.029_bib0295","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/nrd4308","article-title":"Opportunities and challenges in the discovery of allosteric modulators of GPCRs for treating CNS disorders","volume":"13","author":"Conn","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.phrs.2016.11.029_bib0300","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1016\/j.neuropharm.2011.06.007","article-title":"Group II metabotropic glutamate receptor agonists and positive allosteric modulators as novel treatments for schizophrenia","volume":"62","author":"Fell","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2016.11.029_bib0305","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.biopsych.2015.03.016","article-title":"Exploratory analysis for a targeted patient population responsive to the metabotropic glutamate 2\/3 receptor agonist pomaglumetad methionil in schizophrenia","volume":"78","author":"Kinon","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.phrs.2016.11.029_bib0310","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.coph.2014.11.003","article-title":"Group I and group II metabotropic glutamate receptor allosteric modulators as novel potential antipsychotics","volume":"20","author":"Walker","year":"2015","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.phrs.2016.11.029_bib0315","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.neuropharm.2012.05.022","article-title":"mGlu2\/3 and mGlu5 receptors: potential targets for novel antidepressants","volume":"66","author":"Chaki","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2016.11.029_bib0320","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.neuropharm.2012.08.001","article-title":"Cognitive impairment in major depression and the mGlu2 receptor as a therapeutic target","volume":"64","author":"Goeldner","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2016.11.029_bib0325","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1124\/jpet.114.222463","article-title":"Pharmacology of basimglurant (RO4917523, RG7090), a unique metabotropic glutamate receptor 5 negative allosteric modulator in clinical development for depression","volume":"353","author":"Lindemann","year":"2015","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.phrs.2016.11.029_bib0330","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/nrn1763","article-title":"Metabotropic glutamate receptors in the basal ganglia motor circuit","volume":"6","author":"Conn","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.phrs.2016.11.029_bib0335","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/0031-9384(85)90130-1","article-title":"Stress induced by three procedures of deprivation of paradoxical sleep","volume":"35","author":"Coenen","year":"1985","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.phrs.2016.11.029_bib0340","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1034\/j.1399-5618.2003.00038.x","article-title":"Risk factors in relation to an emergence of bipolar disorder: a systematic review","volume":"5","author":"Tsuchiya","year":"2003","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.phrs.2016.11.029_bib0345","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nature06612","article-title":"Identification of a serotonin\/glutamate receptor complex implicated in psychosis","volume":"6","author":"Gonz\u00e1lez-Maeso","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2016.11.029_bib0350","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.neuropharm.2008.05.014","article-title":"Defective group-II metaboropic glutamate receptors in the hippocampus of spontaneously depressed rats","volume":"55","author":"Matrisciano","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2016.11.029_bib0355","doi-asserted-by":"publisher","first-page":"4804","DOI":"10.1073\/pnas.1216100110","article-title":"l-acetylcarnitine causes rapid antidepressant effects through the epigenetic induction of mGlu2 receptors","volume":"19","author":"Nasca","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"18","key":"10.1016\/j.phrs.2016.11.029_bib0360","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1097\/FBP.0b013e3282df3cde","article-title":"The role of hippocampus in the pathophysiology of bipolar disorder","volume":"2007","author":"Frey","year":"2007","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.phrs.2016.11.029_bib0365","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/S0006-3223(02)01911-X","article-title":"Neuronal pathology in the hippocampal area of patients with bipolar disorder: a study with proton magnetic resonance spectroscopic imaging","volume":"53","author":"Bertolino","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.phrs.2016.11.029_bib0370","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/j.1399-5618.2012.01013.x","article-title":"Hippocampal volumes in bipolar disorders: opposing effects of illness burden and lithium treatment","volume":"14","author":"Hajek","year":"2012","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.phrs.2016.11.029_bib0375","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1111\/bdi.12204","article-title":"Neuroprogressive effects of lifetime illness duration in older adults with bipolar disorder","volume":"16","author":"Gildengers","year":"2014","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.phrs.2016.11.029_bib0380","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.biopsych.2013.09.027","article-title":"Structural abnormalities in bipolar euthymia: a multicontrast molecular diffusion imaging study","volume":"76","author":"Canales-Rodr\u00edguez","year":"2014","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.phrs.2016.11.029_bib0385","article-title":"Volume, metabolites and neuroinflammation of the hippocampus in bipolar disorder \u2013 a combined magnetic resonance imaging and positron emission tomography study","author":"Haarman","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.phrs.2016.11.029_bib0390","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.biopsych.2014.06.020","article-title":"In vivo hippocampal subfield volumes in schizophrenia and bipolar disorder","volume":"77","author":"Haukvik","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.phrs.2016.11.029_bib0395","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jad.2014.11.001","article-title":"Hippocampal structure and function in individuals with bipolar disorder: a systematic review","volume":"174","author":"Otten","year":"2015","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.phrs.2016.11.029_bib0400","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.pscychresns.2015.05.012","article-title":"Volume and shape analysis of subcortical brain structures and ventricles in euthymic bipolar I disorder","volume":"233","author":"Quigley","year":"2015","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.phrs.2016.11.029_bib0405","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1038\/npp.2013.218","article-title":"Impulsivity and risk taking in bipolar disorder and schizophrenia","volume":"39","author":"Reddy","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.phrs.2016.11.029_bib0410","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1124\/jpet.105.091074","article-title":"A selective allosteric potentiator of mGluR2 receptors has similar effects to an orthosteric mGluR2\/3 agonist in mouse models predictive of antipsychotic activity","volume":"15","author":"Galici","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661816305709?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661816305709?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T12:28:32Z","timestamp":1536236912000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661816305709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":82,"alternative-id":["S1043661816305709"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2016.11.029","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Paradoxical sleep deprivation in rats causes a selective reduction in the expression of type-2 metabotropic glutamate receptors in the hippocampus","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2016.11.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}